(-0.01%) 5 478.00 points
(-0.02%) 38 812 points
(0.02%) 19 926 points
(0.27%) $80.55
(1.11%) $2.82
(0.11%) $2 331.50
(-0.43%) $29.27
(-0.11%) $969.80
(0.03%) $0.932
(-0.11%) $10.64
(0.08%) $0.788
(-1.86%) $86.80
Live Chart Being Loaded With Signals
Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide...
Stats | |
---|---|
Šios dienos apimtis | 0 |
Vidutinė apimtis | 1.47M |
Rinkos kapitalizacija | 0.00 |
EPS | $-2.54 ( Q4 | 2022-02-23 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-9.86 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $1.142 (1.14%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-03-11 | Nova Tina Susan | Sell | 17 776 | Common Stock |
2022-03-11 | Nova Tina Susan | Sell | 3 067 | Common Stock |
2022-03-11 | Nova Tina Susan | Sell | 4 800 | Stock Option (right to buy) |
2022-03-11 | Nova Tina Susan | Sell | 15 000 | Stock Option (right to buy) |
2022-03-11 | Nova Tina Susan | Sell | 5 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
0.00 |
Last 100 transactions |
Buy: 416 073 | Sell: 1 553 839 |
Tūris Koreliacija
Arena Pharmaceuticals Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Arena Pharmaceuticals Inc Koreliacija - Valiuta/Žaliavos
Arena Pharmaceuticals Inc Finansinės ataskaitos
Annual | 2021 |
Pajamos: | $54 000.00 |
Bruto pelnas: | $0.00 (0.00 %) |
EPS: | $-11.26 |
FY | 2021 |
Pajamos: | $54 000.00 |
Bruto pelnas: | $0.00 (0.00 %) |
EPS: | $-11.26 |
FY | 2020 |
Pajamos: | $319 000 |
Bruto pelnas: | $319 000 (100.00 %) |
EPS: | $-7.39 |
FY | 2019 |
Pajamos: | $806.43M |
Bruto pelnas: | $0.00 (0.00 %) |
EPS: | $7.99 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Arena Pharmaceuticals Inc
Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. The company's investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clinical trial for Crohn's disease, Phase II clinical trial for alopecia areata, Phase III clinical trial for atopic dermatitis, and Phase IIb clinical trial for eosinophilic esophagitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; APD418 that is in Phase II clinical trial for acute heart failure; and Temanogrel for coronary microvascular obstruction that is in Phase II clinical trial. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Eisai Co., Ltd. and Eisai Inc.; Boehringer Ingelheim International GmbH; Beacon Discovery, Inc.; and Aristea Therapeutics, Inc. Arena Pharmaceuticals, Inc. was incorporated in 1997 and is based in Park City, Utah. As of March 11, 2022, Arena Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.